Pharmafile Logo
Pharmafocus logo
Advanced Search

Oncology

Showing 15 posts of 308 posts found.

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026
Research and Development Infinitopes, Oncology

Infinitopes, a clinical stage biotechnology company specialising in oncology, has announced the receipt of an additional $15.4m in seed funding, …

News

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026
Research and Development Oncology, QV Bioelectronics, glioblastoma

QV Bioelectronics, a medtech business specialising in implants for cancer treatment, has announced that it has received £4.5m in funding …

News

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026
Research and Development Iktos, Oncology, Pierre Fabre Laboratories

Pierre Fabre Laboratories and Iktos have announced a new collaboration intended to discover and develop new small-molecule drug candidates for …

News

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026
Research and Development Bio-Sourcing, Oncology, Zerion Pharma, breast cancer

Bio-Sourcing and Zerion Pharma have announced that their collaboration to develop an oral form of the monoclonal antibody trastuzumab for …

News

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026
Research and Development Biocartis, Mayo Clinic, Oncology, breast cancer

Biocartis has announced a research collaboration with Mayo Clinic in the US, aiming to develop an accelerated sample-to-answer test resulting …

News

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026
Research and Development Blue Earth Therapeutics, Oncology, prostate cancer

Blue Earth Therapeutics, a clinical-stage company specialising in targeted radiotherapeutics, has announced that the first UK patient has received its …

News

Breast Cancer Now study to explore personalised drug doses

December 9, 2025
Research and Development Breast Cancer Now, Oncology

Breast Cancer Now has announced a new study to evaluate whether personalised drug doses could improve quality of life for …

News

Samsung Bioepis announces launch of two new denosumab biosimilars in Europe

December 4, 2025
Sales and Marketing Oncology, Osteoporosis, Samsung Bioepis

Samsung Bioepis has announced the European launch of Obodence and Xbryk, two new denosumab biosimilars approved for the treatment of …

News

Sandoz launches two new bone disease biosimilars in Europe

December 3, 2025
Sales and Marketing Oncology, Osteoporosis, Sandoz

Sandoz has announced the European launch of two new bone disease biosimilars. Wyost (denosumab 120 mg) is approved for the …

News

Medicus Pharma shares updates on basal cell carcinoma trials

December 2, 2025
Research and Development Medicus Pharma, Oncology

Medicus Pharma has announced updates on the progress of SKNJCT-003 and SKNJCT-004, its clinical trials studying the efficacy of a …

News

One-carbon Therapeutics starts new cancer therapy trial

November 27, 2025
Research and Development Oncology, One-carbon Therapeutics

Clinical-stage biotechnology company One-carbon Therapeutics has announced that the first subject has been dosed in its clinical trial for TH9619, …

News

Accession Therapeutics doses first patient in new cancer immunotherapy trial

November 26, 2025
Research and Development Accession Therapeutics, Oncology

Biopharmaceutical company Accession Therapeutics has announced the dosing of the first patient in the phase 1 clinical trial of TROCEPT-01 …

News
Press release

ViVac Pharma appoints Keren Leshem as CEO

November 26, 2025
CEO, Oncology, ViVac Pharma

Early-stage biotechnology company ViVac Pharma has appointed Keren Leshem as its new CEO. Leshem brings almost 30 years of experience …

Appointment

Rethinking oncology trial endpoints with generalised pairwise comparisons

November 4, 2025
Research and Development EMA, FDA, Oncology, One2Treat, clinical trials, generalised pairwise comparisons, net treatment benefit, oncology

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival (OS) and progression-free survival (PFS) …

Feature

Five Facts about Breast Cancer

October 2, 2025
Medical Communications Breast Cancer Awareness Month, Five Facts, Oncology, breast cancer

1 There are striking inequities in breast cancer burden regarding the Human Development Index (HDI), the United Nation’s measure of …

Feature
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026